FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides)
Clinical trial NCT02448381 · COMPLETED
Trial details
- NCT number
- NCT02448381
- Sponsor
- Soligenix
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2020-06-01
- Enrollment
- 169
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.